FDA Warns Marketers of Unapproved ‘Chelation’ Drugs

 

 Federal regulators are warning eight companies to stop selling so called ‘chelation’ products that claim to treat a range of disorders from autism to Alzheimer’s disease.

The Food and Drug Administration (FDA) says the companies have not proven their products are safe and effective in treating autism spectrum disorder, cardiovascular disease, macular degeneration, Parkinson’s disease or any other serious illness. Some of the companies also claim their products can detect the presence of heavy metals in the body in an attempt to justify the need for chelation therapy.

FDA compliance expert Deborah Autor says the companies are preying on people made vulnerable because of serious illness.

“These products are dangerously misleading because they are targeted to patients with serious conditions and limited treatment options,” says Autor.

Read the entire article on the FDA website ›

Medication Safety Alerts

FDA Safety Alerts

Show Your Support!

ISMP needs your help to continue our life saving work